Coronavirus: Commission approves new contract for a potential COVID-19 vaccine with Novavax
The European Commission yesterday approved its seventh Advanced Purchase Agreement (APA) with a pharmaceutical company to ensure access to a potential vaccine against COVID-19 in Q4 of 2021 and in 2022.
Under this contract, Member States will be able to purchase up to 100 million doses of the Novavax vaccine, with an option for 100 million additional doses over the course of 2021, 2022, and 2023, once reviewed and approved by EMA as safe and effective. Member States will also be able to donate vaccines to lower and middle-income countries or to re-direct them to other European countries.
Yesterday's contract complements an already broad portfolio of vaccines to be produced in Europe, including the contracts with AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNtech-Pfizer, CureVac, Moderna and the concluded exploratory talks with Valneva. It represents another key step towards ensuring that Europe is well prepared to face the COVID-19 pandemic.
The President of the European Commission, Ursula von der Leyen, yesterday said:
“As new coronavirus variants are spreading in Europe and around the world, this new contract with a company that is already testing its vaccine successfully against these variants is an additional safeguard for the protection of our population. It further strengthens our broad vaccine portfolio, to the benefit of Europeans and our partners worldwide.”
Stella Kyriakides, Commissioner for Health and Food Safety, yesterday said:
“Vaccinations in the EU are advancing and we are closer to our target of 70% fully vaccinated citizens by the end of summer. Our new agreement with Novavax expands our vaccine portfolio to include one more protein-based vaccine, a platform showing promise in clinical trials. We will continue working tirelessly to ensure that our vaccines continue to reach citizens in Europe and around the world, to end the pandemic as quickly as possible.”
Novavax is a biotechnology company developing next-generation vaccines for serious infectious diseases. Their COVID-19 vaccine is already under rolling review by EMA in view of a potential market authorisation.
The Commission has taken a decision to support this vaccine based on a sound scientific assessment, the technology used, the company's experience in vaccine development and its production capacity to supply the whole of the EU.
Latest News from
EIB Board approves €4 billion credit line along with the EMBRACE Advisory Platform to support the integration of refugees from Ukraine in EU countries20/05/2022 09:25:00
The Board of Directors of the European Investment Bank (EIB) recently (18 May 2022) approved a €4 billion credit line (or programme loan) to help national authorities, cities, regions and local communities in all EU Member States address urgent investment needs and help welcome and integrate people fleeing the war against Ukraine.
Joint press release by the Eurogroup President, Paschal Donohoe, and Finance Minister Sigrid Kaag following their meeting in The Hague19/05/2022 16:33:00
Minister of Finance Sigrid Kaag and the President of the Eurogroup, Paschal Donohoe, met in The Hague on Wednesday.
GCC: EU unveils Strategic Partnership with the Gulf19/05/2022 15:25:00
The High Representative and the European Commission yesterday adopted a Joint Communication on a 'Strategic Partnership with the Gulf' with the aim to broaden and deepen the European Union (EU)'s cooperation with the Gulf Cooperation Council (GCC) and its Member countries.
REPowerEU: A plan to rapidly reduce dependence on Russian fossil fuels and fast forward the green transition*19/05/2022 14:33:00
The European Commission yesterday presented the REPowerEU Plan, its response to the hardships and global energy market disruption caused by Russia's invasion of Ukraine.
Union for the Mediterranean (UfM) Member States commit to tackling the employment and employability challenges of the most vulnerable, especially among youth and women19/05/2022 13:25:00
The fifth Union for the Mediterranean (UfM) Ministerial on Employment and Labour, held on 17 and 18 May in Marrakech, Morocco, focused on “Employment and employability of the most vulnerable, especially among youth and women”.
EU steps up action to strengthen EU defence capabilities, industrial and technological base: towards an EU framework for Joint defence procurement19/05/2022 12:38:00
In response to the European Council tasking at the Versailles Summit, the Commission and the High Representative yesterday presented an analysis of the defence investment gaps, and propose further measures and actions necessary to strengthen the European defence industrial and technological base.
Ukraine: Commission presents plans for the Union's immediate response to address Ukraine's financing gap and the longer-term reconstruction19/05/2022 11:33:00
The Commission yesterday set out plans in a Communication for the EU's immediate response to address Ukraine's financing gap, as well as the longer-term reconstruction framework.
State aid: Commission approves a €30 million Maltese scheme to support the importation, manufacturing and wholesale of grains in context of Russia's invasion of Ukraine19/05/2022 10:33:00
The European Commission has approved a €30 million Maltese scheme to support companies active in the importation, manufacturing and wholesale of grains and other similar products in the context of Russia's invasion of Ukraine.
EU allocates €25 million in humanitarian aid for Palestinians17/05/2022 10:25:00
The EU yesterday announced €25 million in humanitarian aid to meet the basic needs of vulnerable Palestinians in the West Bank, East Jerusalem and Gaza.